What is the indication for naloxone under ICEMA standing orders?

• A. Suspected opioid overdose with respiratory depression or decreased mental status.
• B. Pain management in opioid-naive patients
• C. To treat seizures in eclampsia
• D. For tachycardia due to stimulant overdose

Answer: (A)

Naloxone is an opioid receptor antagonist used to reverse opioid toxicity by displacing opioids from mu receptors, thereby restoring respiratory drive and mental status. Under ICEMA standing orders, the indication is suspected opioid overdose with respiratory depression or decreased mental status, because that scenario reflects opioid-induced impairment that naloxone can rapidly reverse. Begin with a small dose and titrate to achieve improved breathing and consciousness while monitoring the patient closely for the need to repeat doses, since some opioids are longer-acting than naloxone. Be aware that reversal can precipitate withdrawal in opioid-dependent individuals and that naloxone is not a pain medication, nor is it appropriate for non-opioid overdoses such as seizures in eclampsia or tachycardia from stimulant overdose.